It was the comment made by Hosken Consolidated Investments (HCI) CEO Johnny Copelyn in the group’s recently released annual report that might prompt investors to revisit helium hopeful Renergen, the enfant terrible of the JSE’s commodity sector.

IM last covered Renergen in March, when the share price was R20.50 and we recommended investors keep persevering with it. The share, at the time of writing, has dribbled down closer to R18.50...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.